New Psoriasis Drug Shows Promise in Trials – Philly.com
New Psoriasis Drug Shows Promise in TrialsPhilly.comWEDNESDAY, July 9, 2014 (HealthDay News) — A new psoriasis drug delivered dramatic results in two clinical trials, perhaps heralding an effective new treatment for patients with the chronic skin disease. The drug, secukinumab, was stacked up against …New Drug for Plaque Psoriasis Shows Promise in Two Clinical TrialsHealthlineResearch finds promising new treatment for psoriasisPhys.OrgNovartis' secukinumab tops Enbrel in psoriasisPMLiVEFierceBiotechall 34 news articles »
[monetize id=”1″]
[monetize id=”2″]
FDA: New Psoriasis Drug Wins Approval – MedPage Today
FDA: New Psoriasis Drug Wins ApprovalMedPage TodayAn FDA advisory committee voted 7-0 that the benefits of secukinumab in moderate-to-severe plaque psoriasis appear to outweigh the risks, supporting the drug's approval. Note that secukinumab is a monoclonal antibody that binds to interleukin (IL)-17A …and more »
